HCPCS Code J7513
Daclizumab, parenteral, 25 mg
| Short Description | Daclizumab, parenteral |
|---|---|
| Year | 2026 |
| Coverage Code | D = Special coverage instructions apply |
| Action Code | D = Discontinue procedure or modifier code |
| Action Effective Date | January 01, 2026 |
| Code Added Date | January 01, 1999 |
| Pricing Indicator | 51 = Drugs |
| Type of Service | 1 = Medical care G = Immunosuppressive drugs |